ArticleJournal of virology2018
Tumor Necrosis Factor-Mediated Survival of CD169
Open access · hybridAbstract read
In one paragraph
Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 74 citations in OpenAlex.
- Sulfated glycosaminoglycans inhibit LCMV entry and modulate antiviral immunity and pathology.EMBO molecular medicine · 2026Article
- Role of myeloid cells expressing CD169/Siglec-1 in host-pathogen interactions.FEMS microbiology reviews · 2026Review
- A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients.International journal of molecular sciences · 2024Article
- Exploring the Molecular Basis of Vesicular Stomatitis Virus Pathogenesis in Swine: Insights from Expression Profiling of Primary Macrophages Infected with M51R Mutant Virus.Pathogens (Basel, Switzerland) · 2023Article
- Innate immune surveillance of the circulation: A review on the removal of circulating virions from the bloodstream.PLoS pathogens · 2022Review
- Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease.Frontiers in medicine · 2022Review
- MCPIP1 Enhances TNF-α-Mediated Apoptosis through Downregulation of the NF-κB/cFLIP Axis.Biology · 2021Article
- Functions of CD169 positive macrophages in human diseases (Review).Biomedical reports · 2021Review
- Validation of a Quick Flow Cytometry-Based Assay for Acute Infection Based on CD64 and CD169 Expression. New Tools for Early Diagnosis in COVID-19 Pandemic.Frontiers in medicine · 2021Article
- Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome.The EMBO journal · 2019Article
- Macrophage Depletion Mitigates Platelet Aggregate Formation in Splenic Marginal Zone and Alleviates LPS-Associated Thrombocytopenia in Rats.Frontiers in medicine · 2019Article
- Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.Clinical and experimental immunology · 2019Review
- CD169Frontiers in immunology · 2018Review
- Increased Virulence of an Epidemic Strain of Vesicular Stomatitis Virus Is Associated With Interference of the Innate Response in Pigs.Frontiers in microbiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 11 institutions in 9 countries.
Prashant V ShindeDepartment of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Haifeng C XuDepartment of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Sathish Kumar ManeyDepartment of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Andreas KloetgenDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
Sukumar NamineniInstitute of Virology, TU Munich, Munich, Germany.
Yuan ZhuangDepartment of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Nadine HonkeDepartment of Rheumatology, Hiller Research Center Rheumatology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Namir ShaabaniDepartment of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, USA.
Nicolas BelloraInstituto Andino Patagónico de Tecnologías Biológicas y Geoambientales (IPATEC), Universidad Nacional del Comahue-CONICET, Bariloche, Argentina.
Mareike DoerrenbergDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
Mirko TrillingInstitute for Virology of the University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Vitaly I PozdeevDepartment of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
Nico van RooijenDepartment of Cell Biology, Vrije University Medical Center, Amsterdam, Netherlands.
Stefanie ScheuInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Klaus PfefferInstitute of Medical Microbiology and Hospital Hygiene, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Paul R CrockerDivision of Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee, United Kingdom.
Masato TanakaLaboratory of Immune Regulation, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Sujitha DuggimpudiDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
Percy KnolleInstitute of Molecular Immunology, Technische Universität Munich and Helmholtz Zentrum Munich, Munich, Germany.
Mathias HeikenwalderInstitute of Virology, TU Munich, Munich, Germany.
Jürgen RulandInstitut für Klinische Chemie und Pathobiochemie, Klinikum rechts der Isar, Technische Universität Munich, Munich, Germany.
Tak W MakPrincess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada.
Dirk BrennerDepartment of Infection and Immunity, Experimental and Molecular Immunology, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
Aleksandra A PandyraInstitute of Immunology, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Jessica I HoellDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
Arndt BorkhardtDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Center for Child and Adolescent Health, Heinrich Heine University, Medical Faculty, Düsseldorf, Germany.
Dieter HäussingerDepartment of Gastroenterology, Hepatology, and Infectious Diseases, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Karl S Lang *Institute of Immunology, Medical Faculty, University of Duisburg-Essen, Essen, Germany.
Philipp A Lang *Department of Molecular Medicine II, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany langp@uni-duesseldorf.de.
Heinrich Heine University Düsseldorf · DEUniversity of Duisburg-Essen · DEGerman Cancer Research Center · DEHelmholtz Zentrum München · DELuxembourg Institute of Health · LUNational University of Comahue · ARPrincess Margaret Cancer Centre · CAScripps Research Institute · USTokyo University of Pharmacy and Life Sciences · JPUniversity of Dundee · GBVrije Universiteit Amsterdam · NL
Funding
No grant is acknowledged in the PubMed record.
Abstract
Innate immune activation is essential to mount an effective antiviral response and to prime adaptive immunity. Although a crucial role of CD169
Indexed as
Adaptive ImmunityAnimalsImmunity, InnateInterferon Type IMacrophagesMiceMice, Inbred C57BLMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinReceptors, Tumor Necrosis Factor, Type ISialic Acid Binding Ig-like Lectin 1Transcription Factor RelATumor Necrosis Factor-alphaVesicular StomatitisVesiculovirusVirus ReplicationInterferon Type IMalt1 protein, mouseMucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinReceptors, Tumor Necrosis Factor, Type IRela protein, mouseSialic Acid Binding Ig-like Lectin 1Tnfrsf1a protein, mouseTranscription Factor RelATumor Necrosis Factor-alphainnate immunityinterferoninterferonsMALT1NF-κBTNFtumor necrosis factor
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.